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Article: The long-term clinical efficacy of biofeedback therapy for patients with constipation or fecal incontinence
(J Neurogastroenterol Motil 2010;16:177-185)
Chronic constipation and incontinence are common symp-
toms especially in western countries.
1 However, these problems 
are increasing among Asians probably due to the rise in aging 
population and westernization of diet. The pathogenesis of con-
stipation varies in patients with colonic transit delay, dyssynergic 
defecation, or both, while the cause of incontinence is often weak-
ening or structural defect of anal sphincters.
2
Constipated patients may respond either to fiber-fluid sup-
plementation, prokinetics, or judicious use of laxatives. Among 
non-responders, outlet obstructive type of dysfunction seems par-
ticularly common; it affects up to 50% of patients with chronic 
constipation who are referred to a tertiary care center.
3 In patients 
with incontinence, biofeedback therapy is the first line treatment 
before considering surgery.
3
　Biofeedback therapy is a learning strategy originating from 
psychological learning theories, more specifically from ‘instru-
mental learning’ and ‘operant conditioning.’
4 This therapy has 
been reported to be effective in constipation and incontinence. 
Recently, three randomized controlled trials (RCTs) have been 
published between 2006 to 2007 which provide definitive evi-
dence for the efficacy of biofeedback in adults with dyssynergic 
defecation.
5-7 Biofeedback treatment is also effective in reducing 
incontinence in more than two-thirds of patients and is generally 
well accepted.
2 
In this issue of Journal of Neurogastroenterology and 
Motility, Lee et al. reported the result of biofeedback therapy for 
patients with constipation and incontinence in a single center. 
Their report indicated unsatisfactory symptom improvements for 
both constipation and incontinence, although the improvement 
lasted at least a year in patients with excellent responses. This is 
rather a disappointing news for patients with constipation and in-
continence waiting for hopeful results of novel treatment. 
However, it is too early to be disappointed.
When we read an article regarding the results of treatment in 
specific patients group, several factors such as enrolled patients 
group (strict diagnostic criteria), treatment method, and evalua-
tion of treatment efficacy should be carefully considered. I sug-
gest to meticulously analyze these factors in this article before 
considering biofeedback treatment is as not so effective for con-
stipation and incontinence.Biofeedback Therapy in Constipation and Incontinence
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Firstly, not every enrolled patient might have been exactly 
suitable for biofeedback therapy. In randomized controlled trial, 
this therapy is effective in 70 to 86% of patients with dyssynergic 
defecation.
5-7 The diagnostic criteria for dyssynergic defecation is 
well described in a recent review,
8 which includes dyssynergic 
anorectal manometric findings reflecting abnormal relexation 
pattern or inadequate propulsive force plus abnormal findings 
from balloon expulsion test, defecography, or colon transit time.
8 
It is proven in RCT that biofeedback benefits only patients with 
outlet dysfunction, and no patients with isolated slow transit 
constipation.
9 In this article, as the authors mentioned in the dis-
cussion, the diagnostic criteria for constipation were not defined, 
which could have led to the low response rate of biofeedback 
among the enrolled constipated patients since patients with slow 
transit constipation might have been included. It is under-
standable to try biofeedback therapy in medically intractable 
constipation. However, analyzing the response rate of the therapy 
according to the pathogenesis of the diseases would be beneficial. 
Our group also tried to evaluate the variables to predict biofeed-
back responsiveness and found the defecation index and pelvic 
floor dyssynergia to be the factors influencing the responses by 
multivariate analysis.
10 However, there is no consensus for mark-
ers in predicting the biofeedback response. In the future, we 
should set up protocols to select the suitable patients for biofeed-
back therapy using adequate biomarkers. 
Secondly, the method and protocol of biofeedback therapy 
should be reviewed. The effectiveness of biofeedback training de-
pends in part on the skills of the biofeedback therapist and the se-
lection of particular techniques used for the training.
2 In a recent 
RCT, the patients were treated by a physician who highly experi-
enced in biofeedback training.
11 The description of the biofeed-
back protocol was adequate in this article although there is a pos-
sibility that better protocol and method to induce more fair 
response. In addition, this protocol lacked the sessions for sensory 
retraining or strengthening of propulsive force for indicated 
patients.
12
Thirdly, the evaluation criteria for the response rate are 
important. The subjective reporting system including 4 catego-
ries used by authors are reasonable and widely used. However, 
the evaluation of efficacy including objective and subjective in-
formations will add to the knowledge on the effectiveness of this 
therapy.
They reported intriguing observation of a higher sensory vol-
ume in nonresponsive than in responsive group. As the authors 
have discussed, there might be a possibility that rectal hypo-
sensitivity is one of the parameters to predict poor response of bi-
ofeedback therapy.
12 Our group suggested electrical stimulation 
to be helpful for patients with rectal hyposensitivity, especially 
among those who were unresponsive to biofeedback therapy.
13,14 
Further study is warranted to evaluate the importance of this nov-
el mechanism in constipation. 
In summary, the article by Lee et al. provided valuable in-
formation about biofeedback therapy in Korean patients with 
constipation and incontinence. However, the overall response 
rate might have been underestimated due to patient’s selection 
and/or short treatment period. The promising finding is the 
long-term maintenance of improvement in the responsive 
patients. They also suggested rectal hyposensitivity as a possible 
biomarker for predicting biofeedback responsiveness which is a 
valuable and plausible hypothesis. Further study is warranted to 
evaluate the effectiveness of biofeedback therapy and to develop 
biomarkers to predict the response of this therapy in Asian pa-
tients with constipation and incontinence.
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